Greg Tourangeau - Mar 11, 2022 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Controller
Signature
/s/ Gregory Tourangeau
Stock symbol
FULC
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
3
Date filed
3/14/2022, 04:15 PM
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FULC Common Stock 13K Mar 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 685 $7.84 Direct F1
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 1.34K $11.06 Direct F2
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 374 $16.00 Direct F3
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 3.41K $16.87 Direct F4
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 7.28K $13.09 Direct F5
holding FULC Stock Option (right to buy) Mar 11, 2022 Common Stock 9.87K $12.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an option to purchase a total of 2,192 shares on January 22, 2019. 1,507 shares underlying the option were previously exercised by the reporting person. The shares underlying the option are scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2019, subject to continued service.
F2 The reporting person received an option to purchase a total of 3,571 shares on May 21, 2019. 2,232 shares underlying the option were previously exercised by the reporting person. The shares underlying the option are scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of May 15, 2019, subject to continued service.
F3 This option was granted on July 18, 2019 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2019, subject to continued service.
F4 This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service.
F5 This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service.
F6 This option was granted on January 26, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service.